Mahkameh Tracy, MD
Family Medicine · Castle Rock, CONPI 1669634739
Payments from drug & device makers
Across 149 payments — averaging $26.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$623
- AbbVie$591
- Bayer$572
- Pfizer$409
- Amgen$215
- Idorsia Pharmaceuticals US Inc$179
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,981100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $623 |
| AbbVie(2 entities) | 21 | $591 |
| Bayer | 14 | $572 |
| Pfizer | 23 | $409 |
| Amgen | 6 | $215 |
| Idorsia Pharmaceuticals US Inc | 5 | $179 |
| Otsuka America Pharmaceutical, Inc. | 8 | $166 |
| Lilly USA, LLC | 10 | $162 |
| Globus Medical | 1 | $127 |
| Gilead | 1 | $121 |
| Exact Sciences | 5 | $115 |
| Bausch Health US, LLC | 6 | $113 |
| Merck | 7 | $111 |
| Novo Nordisk | 6 | $105 |
| GSK | 4 | $79 |
| Genentech USA, Inc. | 2 | $40 |
| Tris Pharma Inc | 1 | $39 |
| Boston Scientific | 2 | $38 |
| Boehringer Ingelheim | 2 | $34 |
| Harmony Biosciences LLC | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Eisai Inc. | 1 | $22 |
| Organon | 1 | $17 |
| Corium, LLC | 1 | $15 |
| Dermira, Inc. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,981 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wixela InhubFluticasone Propion/Salmeterol | 14 | $2,439 |
| Levothyroxine Sodium | 101 | $1,159 |
| Atorvastatin Calcium | 98 | $1,084 |
| Rosuvastatin Calcium | 52 | $742 |
| Trazodone Hcl | 60 | $720 |
| Azelastine Hcl | 31 | $665 |
| Lisinopril | 76 | $645 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $608 |
| Gabapentin | 33 | $538 |
| Omeprazole | 57 | $531 |
| Tamsulosin Hcl | 25 | $497 |
| Simvastatin | 42 | $492 |
| Metoprolol Succinate | 22 | $470 |
| Bupropion XlBupropion Hcl | 15 | $445 |
| Escitalopram Oxalate | 22 | $441 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Castle Rock
- Larry OdekirkCastle Rock$6.3M
- Belton HallmarkCastle Rock$19K
- Aaron BlockCastle Rock$17K
- Clint FlanaganDacono$7.6M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.